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Abstract
Across decades of co-circulation in humans, influenza A subtypes H1N1 and H3N2 have
caused seasonal epidemics characterized by different age distributions of cases and mortal-
ity. H3N2 causes the majority of severe, clinically attended cases in high-risk elderly
cohorts, and the majority of overall deaths, whereas H1N1 causes fewer deaths overall, and
cases shifted towards young and middle-aged adults. These contrasting age profiles may
result from differences in childhood imprinting to H1N1 and H3N2 or from differences in evo-
lutionary rate between subtypes. Here we analyze a large epidemiological surveillance data-
set to test whether childhood immune imprinting shapes seasonal influenza epidemiology,
and if so, whether it acts primarily via homosubtypic immune memory or via broader, hetero-
subtypic memory. We also test the impact of evolutionary differences between influenza
subtypes on age distributions of cases. Likelihood-based model comparison shows that nar-
row, within-subtype imprinting shapes seasonal influenza risk alongside age-specific risk
factors. The data do not support a strong effect of evolutionary rate, or of broadly protective
imprinting that acts across subtypes. Our findings emphasize that childhood exposures can
imprint a lifelong immunological bias toward particular influenza subtypes, and that these
cohort-specific biases shape epidemic age distributions. As a consequence, newer and less
“senior” antibody responses acquired later in life do not provide the same strength of protec-
tion as responses imprinted in childhood. Finally, we project that the relatively low mortality
burden of H1N1 may increase in the coming decades, as cohorts that lack H1N1-specific
imprinting eventually reach old age.
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Author summary
Influenza viruses of subtype H1N1 and H3N2 both cause seasonal epidemics in humans,
but with different age-specific impacts. H3N2 causes a greater proportion of cases in older
adults than H1N1, and more deaths overall. People tend to gain the strongest immune
memory of influenza viruses encountered in childhood, and so differences in H1N1 and
H3N2’s age-specific impacts may reflect that individuals born in different eras of influenza
circulation have been imprinted with different immunological risk profiles. Another idea
is that H3N2 may be more able to infect immunologically experienced adults because it
evolves slightly faster than H1N1 and can more quickly escape immune memory. We ana-
lyzed a large epidemiological data set and found that birth year-specific differences in
childhood immune imprinting, not differences in evolutionary rate, explain differences in
H1N1 and H3N2’s age-specific impacts. These results can help epidemiologists under-
stand how epidemic risk from specific influenza subtypes is distributed across the popula-
tion and predict how population risk may shift as differently imprinted birth years grow
older. Further, these results provide immunological clues to which facets of immune
memory become biased in childhood, and then later play a strong role in protection dur-
ing seasonal influenza epidemics.
Introduction
Childhood influenza exposures leave an immunological imprint, which has reverberating, life-
long impacts on immune memory. Foundational work on original antigenic sin [1] and anti-
genic seniority [2] shows that individuals maintain the highest antibody titers against
influenza strains encountered in childhood. But how these serological patterns map to func-
tional immune protection, and shape birth year-specific risk during outbreaks, remains an
active area of inquiry. One open question is the breadth of cross-protection provided by
immune memory imprinted in childhood.
We define immune imprinting as a lifelong bias in immune memory of, and protection
against, the strains encountered in childhood. Such biases most likely become entrenched as
subsequent exposures back-boost existing memory responses, rather than stimulating de novo
responses [3]. By providing particularly robust protection against certain antigenic subtypes,
or clades, imprinting can provide immunological benefits, but perhaps at the cost of equally
strong protection against variants encountered later in life. For example, every modern influ-
enza pandemic has spared certain birth cohorts, presumably due to cross-protective memory
primed in childhood [4–10]. Recently, we showed that imprinting also protects against novel,
emerging avian influenza viruses of the same phylogenetic group of hemagglutinin (HA) as
the first childhood exposure [9,11]. Imprinting may additionally shape birth year-specific risk
from seasonal influenza [12–14], but the importance of broadly protective immunity in this
context is still being evaluated [15–17].
Until recently, narrow cross-protective immunity specific to variants of a single HA subtype
has been considered the primary mode of defense against seasonal influenza. Lymphocyte
memory of variable epitopes on the HA head (i.e. sites at which hemagglutinin antigens of dif-
ferent subtypes show limited homology) drives this narrow, within-subtype protection, which
is the main mechanism of protection from the inactivated influenza vaccine. But a growing
body of evidence shows protection may also be driven by memory of other influenza antigens
(e.g. neuraminidase, NA) [18–20], or by immune response to conserved epitopes, many of
which are found on the HA stalk [11,15,21–23]. Antibodies that target conserved HA epitopes
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can provide broad protection across multiple HA subtypes in the same phylogenetic group
[21,23,24], where HA group 1 contains hemagglutinin subtypes H1 and H2, while group 2
contains H3. Only three HA subtypes have circulated seasonally in humans since 1918, H1, H2
and H3; H1 and H2 belong to phylogenetic group 1, while H3 is in group 2 [11,22,25].
Current thinking stipulates that within a single host, imprinting probably induces multiple
levels of bias in immune memory, to both conserved (broadly protective) and variable (nar-
rowly protective) sites on various influenza antigens. The functional role of any single layer of
imprinted immune memory depends on both immunodominance hierarchies and epidemic
context. Here, we examine which layers of imprinted memory impact risk from seasonal
influenza.
Different breadths of immunity are expected to act differently on influenza epidemiology.
Within-subtype immunity to HA is known to shape seasonal influenza’s epidemiology and
evolution [26], but due to rapid decay in the face of antigenic drift, it would not be expected to
shape cohort-specific imprinting protection across an entire human lifetime [27,28]. Con-
versely, broad, HA group-level immune memory arises when lymphocytes target conserved
HA epitopes. Responses to these conserved epitopes should be more stable over time, and can
play a strong role in defense against unfamiliar influenza strains (e.g. novel, avian or pandemic
subtypes [11,21,23,24,29,30], but are not traditionally though to act strongly against familiar,
seasonal influenza subtypes. However, responses to the conserved HA stem have recently been
identified as an independent correlate of protection against seasonal influenza [15], and might
play a particularly strong role against drifted seasonal strains whose variable HA epitopes have
become unrecognizable. Thus, childhood immune imprinting may determine which birth
cohorts are primed for effective defense against seasonal strains with conserved HA epitopes
characteristic of group 1 or group 2, or with variable HA epitopes characteristic of a particular
subtype (H1, H2, etc.). A similar line of reasoning may apply to immunity against NA,
although much less attention has been paid to this antigen.
Since 1977, two distinct subtypes of influenza A, H1N1 and H3N2, have circulated season-
ally in humans, with striking but poorly understood differences in their age-specific impact
[9,12–14,31]. These differences could be associated with childhood imprinting: older cohorts
were almost certainly exposed to H1N1 in childhood (since it was the only subtype circulating
in humans from 1918–1957), and now seem to be preferentially protected against modern sea-
sonal H1N1 variants [9,12–14]. Likewise, younger adults have the highest probabilities of
childhood imprinting to H3N2 (Fig 1), which is consistent with relatively low numbers of clin-
ically attended H3N2 cases in these cohorts. Alternatively, differences in the evolutionary
dynamics of H1N1 and H3N2 could explain the observed age profiles. Subtype H3N2 exhibits
slightly faster drift in its antigenic phenotype than H1N1, and as a result, H3N2 may be better
able to escape pre-existing immunity in immunologically experienced adults, whereas H1N1
may be relatively restricted to causing disease in immunologically inexperienced children [32].
We analyzed a large surveillance data set of relatively severe, clinically attended influenza
cases to test whether cohort effects from childhood imprinting primarily act against variable
epitopes, only providing narrow cross-protection against closely related HA or NA variants of
the same subtype, or against more conserved epitopes, providing broad cross-protection across
HA subtypes in the same phylogenetic group (Fig 1A and 1B). We fitted a suite of models to
data using maximum likelihood and compared models using AIC. In a separate analysis, we
considered the hypothesis that differences in evolutionary rate of H1N1 and H3N2, rather
than imprinting effects, shape differences in age distribution. Our results have implications for
long-term projections of seasonal influenza risk in elderly cohorts [13], who suffer the heaviest
burdens of influenza-related morbidity and mortality, and whose imprinting status will shift
through time as cohorts born during different inter-pandemic eras grow older.
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Fig 1. Model and expectations under different imprinting hypotheses. (A) Reconstructed, birth year-specific probabilities of imprinting (representative
example specific to cases observed in 2015). Throughout the manuscript, group 1 HA subtypes are represented in blue and group 2 subtypes in red. (B)
Expected imprinting protection against H1N1 or H3N2 under the three tested models. (C) Cartoon of expected age distribution of any influenza case, before
controlling for subtype-specific imprinting. The shape of this curve is purely hypothetical, but each of our tested models combined demographic age
distribution with a fitted, age-specific risk step function to generate similar, data-driven curves. (D-F) Fraction of each birth year unprotected by their
childhood imprinting (from A) determines the shape of birth year-specific risk. (G-I) A linear combination of demography plus age-specific risk (as in C), and
birth year-specific risk (as in D-F) give the expected age distribution of H1N1 or H3N2 cases under each model.
https://doi.org/10.1371/journal.ppat.1008109.g001
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Results
Data
The Arizona Department of Health Services (ADHS) provided a dataset containing 9,510 sea-
sonal H1N1 and H3N2 cases from their statewide surveillance system (S1 Data). Cases of all
ages were confirmed to subtype by PCR and/or culture, primarily from virologic testing at the
Arizona State Public Health Laboratory (ASPHL). The ADHS surveillance system aims to
characterize circulating strains from patients across the state with medically attended influ-
enza. Although surveillance does not target specific at-risk groups, relatively severe cases (espe-
cially those tested at hospital labs) are overrepresented in our data, as these cases are most
likely to be medically attended and confirmed to subtype, thus meeting our study inclusion cri-
teria. This is because confirmation to subtype requires a second-line test (PCR or culture);
rapid tests are more common, but do not indicate subtype.
Although the exact collection setting of individual specimens was not always recorded,
ADHS staff internally reviewed reporting source and provider organization of cases in our
data to estimate that roughly 76% were reported and/or submitted by hospital labs or may
have originated at hospital-associated outpatient clinics. In 2016, an ADHS analysis matched
PCR-confirmed cases to hospital discharge data, and found that nearly half of the cases
reported from hospital labs were severe enough to warrant hospital admission (if extrapolated
to other seasons, roughly 38% of the overall data). The rest (also roughly 38% of the overall
data, if extrapolated) were discharged without admission. To obtain a broader representation
of clinically attended cases from across the state, ADHS collaborates with county health
departments, commercial laboratories, and outpatient clinics to receive specimens. We esti-
mate that roughly 8% of the overall data originated in outpatient settings. The remaining 17%
of cases were either tested at commercial labs, or were tested at ASPHL, but with unknown ori-
gin. Ultimately, these data allow us to analyze drivers of relatively severe, clinically attended
cases, but our results cannot be assumed to generalize to mild or asymptomatic cases.
Cases were observed across 22 years of influenza surveillance, from the 1993–1994 influenza
season through the 2014–2015 season, although sample sizes increased dramatically after the
2009 pandemic (Table 1). Sampling changed slightly starting in 2004, when commercial labs
Table 1. PCR-confirmed cases.
Season Confirmed H1N1 Confirmed H3N2
1993–94 0 101
1994–95 12 38
2002–03 71 8
2003–04 0 71
2004–05 0 131
2005–06 1 321
2006–07 212 28
2007–08 196 244
2010–11 472 1204
2011–12 595 348
2012–13 80 1578
2013–14 1475 151
2014–15 5 2109
Total 3119 6332
Data representing the first and second waves of the 2009 H1N1 pandemic (2008–2009 and 2009–2010 seasons) were
excluded.
https://doi.org/10.1371/journal.ppat.1008109.t001
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were first mandated to report positive tests to the state [33], but the vast majority of cases ana-
lyzed (9150/9451) were observed from the 2004–2005 season onwards, after this change had
been implemented.
Following CDC standards, ADHS defines the influenza season as epidemiological week 40
(around early October) through week 39 of the following year [34]. The 2008–2009 and 2009–
2010 influenza seasons spanned the first and second wave, respectively, of the 2009 H1N1 pan-
demic. We did not analyze cases observed during this time period, because age distributions of
cases and immune memory differed during the 2009 pandemic from the normal drivers of sea-
sonal influenza’s immuno-epidemiology of interest to this study [14,21,24]. From the dataset
of 9,510 seasonal cases (defined as any case observed outside the 2008–2009 or 2009–2010 sea-
son), we excluded 58 cases with birth years before 1918 (whose imprinting status could not be
inferred unambiguously), and one case whose year of birth was recorded in error. Ultimately,
we analyzed 9,541 cases.
The model
Reconstructed imprinting patterns. We reconstructed birth year-specific probabilities of
childhood imprinting to H1N1, H2N2 or H3N2 using methods described previously [11].
These probabilities are based on patterns of first childhood exposure to influenza A and reflect
historical circulation (Fig 1A). Most individuals born between pandemics in 1918 and 1957
experienced a first influenza A virus (IAV) infection by H1N1, and middle-aged cohorts born
between pandemics in 1957 and 1968 almost all were first infected by H2N2 (note that because
the first influenza exposure may occur after the first year of life, individuals born in the years
leading up to a pandemic have some probability of first infection by the new pandemic sub-
type, Fig 1A). Ever since its emergence in 1968, H3N2 has dominated seasonal circulation in
humans, and caused the majority of first infections in younger cohorts. However, H1N1 has
also caused some seasonal circulation since 1977, and has imprinted a fraction of all cohorts
born since the mid-1970s (Fig 1A).
Reconstructions assumed children age 0–12 in the year of case observation might not yet
have been exposed to any influenza virus. Interactions between imprinting and vaccination of
naïve infants are plausible, but poorly understood [11,35]. We did not consider childhood vac-
cination effects here; only a small percentage of individuals in the ADHS data were born at a
time when healthy infants were routinely vaccinated against influenza.
Expected age distributions under alternate imprinting models. If HA subtype-level
imprinting protection shapes seasonal influenza risk, primary exposure to HA subtype H1 or
H3 in childhood should provide lifelong protection against modern variants of the same HA
subtype. If imprinting protection acts primarily against specific NA subtypes, lifelong protec-
tion will be specific to N1 or to N2 (Fig 1B). Alternatively, if broad HA group-level imprinting
shapes seasonal influenza risk, then cohorts imprinted to HA subtype H1 or H2 (both group 1)
should be protected against modern, seasonal H1N1 (also group 1), while only cohorts
imprinted to H3 (group 2) would be protected against modern, seasonal H3N2 (also group 2)
(Fig 1B). Collinearities between the predictions of different imprinting models (Fig 1D–1I)
were inevitable, given the limited diversity of influenza antigenic subtypes circulating in
humans over the past century (reflected in Fig 1A). Note that middle-aged cohorts, which
were first infected by H2N2, are crucial, because they provide the only leverage to differentiate
between imprinting at the HA subtype, NA subtype or HA group-level level (Fig 1B).
Our approach distinguishes between age-specific risk factors related to health and social
behavior, and birth year-specific effects related to imprinting. Specifically, age-specific risk
could be influenced by medical factors like age-specific vaccine coverage, age-specific risk of
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severe disease, age-related changes in endocrinology and immunosenescence, or by behavioral
factors like age-assorted social mixing, and age-specific healthcare seeking behavior. These fac-
tors should have similar impacts on any influenza subtype. In contrast, imprinting effects are
subtype- (or group-) specific. Thus, we fit a step function to characterize the shape of age-spe-
cific risk of any confirmed influenza case. Simultaneously, we modeled residual, subtype-spe-
cific differences in risk as a function of birth year, to focus on the possible role of childhood
imprinting. Each tested model used a linear combination of age-specific risk (Fig 1C) and
birth year-specific risk (Fig 1D–1F) to generate an expected distribution of H1N1 or H3N2
cases (Fig 1G–1I). Note that for a given birth cohort, age-specific risk changed across progres-
sive years of case observation (as the cohort got older), whereas birth year-specific risk was
constant over time.
To test quantitatively whether observed subtype-specific differences in incidence were most
consistent with imprinting at the HA subtype, NA subtype or HA group level, or with no con-
tribution of imprinting, we fitted a suite of models to each data set using a multinomial likeli-
hood and then performed model selection using AIC. AIC is used to compare the relative
strength of statistical support for a set of candidate models, each fitted to the same data, and
favors parsimonious models that fit the data well [36,37]. Technical details are provided in the
Methods.
Tested models. We fit a set of four models to the ADHS data set. The simplest model con-
tained only age-specific risk, and more complex models added effects from imprinting at the
HA subtype level, at the HA group level, or at the NA subtype level. The age-specific risk curve
took the form of a step function, in which relative risk was fixed to 1 in age bin 0–4, and one
free parameter was fit to represent relative risk in each of the following 12 age bins: {5–10, 11–
17, 18–24, 25–31, 32–38, 39–45, 46–52, 53–59, 60–66, 67–73, 74–80, 81+}. Within models that
contained imprinting effects, the fraction of individuals in each single year of birth with pro-
tective childhood imprinting was assumed proportional to reductions in risk. Two additional
free parameters quantified the relative risk of a confirmed H1N1 or H3N2 case, given imprint-
ing protection against that seasonal subtype.
Effect of influenza evolutionary rate on age profiles. We used publicly available data
from Nextstrain [38,39], and from one previously published study [40], to calculate annual
antigenic advance, which we defined as the mean antigenic distance between strains of a given
lineage (pre-2009 H1N1, post-2009 H1N1 or H3N2) that circulated in consecutive seasons
(Methods). The “antigenic distance” between two influenza strains is used as a proxy for simi-
larity in antigenic phenotype, and potential for immune cross-protection. A variety of methods
have been developed to estimate antigenic distance using serological data, genetic data, or both
[39–41].
To assess the impact of antigenic evolution on the epidemic age distribution, we tested
whether the proportion of cases in children increased in seasons associated with large anti-
genic changes. If the rate of antigenic drift is a strong driver of age-specific influenza risk, then
the fraction of influenza cases observed in children should be negatively related to annual anti-
genic advance [32]. In other words, strains that have not changed much antigenically since the
previous season should be unable to escape pre-existing immunity in immunologically experi-
enced adults, and more restricted to causing cases in immunologically inexperienced children;
strains that have changed substantially will be less restricted to children.
Subtype-specific differences in age distribution
Seasonal H3N2 epidemics consistently caused more clinically attended cases in older cohorts,
while H1N1 caused a greater proportion of cases in young and middle-aged adults (Figs 2, S1
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and S2). These patterns were apparent whether we compared H3N2 epidemic age distribu-
tions with those caused by the pre-2009 seasonal H1N1 lineage, or with the post-2009 lineage.
Observed patterns are consistent with the predicted effects of cohort-specific imprinting (Fig
1), and with previously reported differences in age distribution of seasonal H1N1 and H3N2
incidence [12–14,31]. See Fig 2 for seasons where H1N1 and H3N2 co-circulated in substantial
numbers, and S1 and S2 Figs. for the entire dataset and alternate smoothing parameters.
Imprinting model selection
The data showed a strong preference for NA subtype-level imprinting over HA subtype-level
imprinting (ΔAIC = 34.54), and effectively no statistical support for broad, HA group-level
imprinting (ΔAIC = 249.06), or for an absence of imprinting effects (ΔAIC = 385.42) (Fig 3,
Table 2). Visual assessment of model fits (Fig 3C and 3D) confirmed that models containing
imprinting effects at the narrow, NA or HA subtype levels provided the best fits to data. The
lack of support for the no-imprinting model suggests that imprinting is important, and shapes
lifelong seasonal influenza risk, just as it does avian-origin influenza (10, 12). However,
imprinting appears to act more narrowly against seasonal influenza than against avian influ-
enza, providing cross protection only to a specific NA or HA subtype, instead of broader, HA
group-level protection. This result is consistent with the idea that immunodominance of
Fig 2. Observed age distributions, Arizona. Points show fraction of confirmed H1N1 or H3N2 cases observed in each single year of age. Lines
show a smoothing spline fit to observed distributions. (A) All confirmed cases in the data (aggregate across all seasons). (B-F) Age distributions
from individual seasons in which both H1N1 and H3N2 circulated (seasons with� 50 confirmed cases of each subtype are shown here. See S1 Fig.
for all seasons).
https://doi.org/10.1371/journal.ppat.1008109.g002
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variable HA epitopes limits the breadth of immune cross protection deployed against familiar,
seasonal influenza subtypes [23,24].
Fig 3. Model fits and model selection. (A) Fitted effects of age, after controlling for demographic age distribution and
(B) imprinting effects from the NA subtype-level imprinting model, which provided the best fit to data. (C-D) Model
fits to observed age distributions of H1N1 (C) and H3N2 (D) case. All models included demographic age distribution
and age-specific risk.
https://doi.org/10.1371/journal.ppat.1008109.g003
Table 2. Maximum likelihood parameter estimates and 95% profile confidence intervals.
Model NA subtype-level imprinting HA subtype-level imprinting HA group-level imprinting No imprinting
ΔAIC 0.00 34.54 249.06 385.42
H1N1 impr. protection 0.36 (0.30–0.44) 0.29 (0.24–0.35) 0.65 (0.56–0.76)
H3N2 impr. protection 0.66 (0.58–0.76) 0.90 (0.78–1.04) 0.70 (0.62–0.82)
Ages 0–4 Reference group: Value fixed to 1
Ages 5–10 0.67 (0.62–0.73) 0.65 (0.60–0.70) 0.65 (0.60–0.71) 0.61 (0.56–0.66)
Ages 11–17 0.33 (0.30–0.37) 0.30 (0.28–0.34) 0.32 (0.30–0.36) 0.29 (0.27–0.33)
Ages 18–24 0.37 (0.34–0.42) 0.34 (0.32–0.38) 0.37 (0.34–0.42) 0.34 (0.31–0.38)
Ages 25–31 0.35 (0.32–0.40) 0.33 (0.30–0.38) 0.34 (0.32–0.38) 0.32 (0.29–0.36)
Ages 32–38 0.3 (0.28–0.35) 0.28 (0.26–0.32) 0.3 (0.27–0.34) 0.27 (0.25–0.31)
Ages 39–45 0.25 (0.22–0.30) 0.22 (0.20–0.26) 0.25 (0.22–0.29) 0.23 (0.21–0.26)
Ages 46–52 0.27 (0.24–0.30) 0.22 (0.20–0.26) 0.26 (0.23–0.29) 0.24 (0.22–0.28)
Ages 53–59 0.25 (0.23–0.30) 0.22 (0.20–0.26) 0.23 (0.21–0.27) 0.23 (0.20–0.26)
Ages 60–66 0.27 (0.24–0.30) 0.29 (0.26–0.33) 0.24 (0.22–0.28) 0.23 (0.21–0.27)
Ages 67–73 0.37 (0.33–0.43) 0.42 (0.37–0.48) 0.34 (0.30–0.38) 0.33 (0.30–0.38)
Ages 74–80 0.57 (0.50–0.64) 0.64 (0.57–0.74) 0.52 (0.46–0.59) 0.5 (0.46–0.57)
Ages 81+ 0.99 (0.88–1.11) 1.12 (1.00–1.26) 0.9 (0.81–1.01) 0.87 (0.80–0.96)
All estimated parameters represent the relative risk of a confirmed case, given the factors listed in the left-hand column. Age-specific risk parameters could take any
positive value. Imprinting parameters could take values in [0,1], consistent with reductions in risk from the imprinted subtype or group. All tested models included age-
specific risk and demographic age distribution.
https://doi.org/10.1371/journal.ppat.1008109.t002
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As expected (see Fig 1G–1I), predictions from the two best models were highly collinear,
except in their risk predictions among middle-aged, H2N2-imprinted cohorts (birth years
1957–1968), and some other minor differences arising from normalization across birth-years.
Fitted risk patterns
Fitted age-specific risk curves took similar forms in all tested models. After controlling for
demographic age distribution, estimated age-specific risk was highest in children and the
elderly, consistent with the buildup of immune memory across childhood, and waning
immune function in the aged (Fig 3A shows the fitted curve from the best model). Estimates
of imprinting parameters were less than one, indicating some reduction in relative risk
(Table 2). Within the best model, estimated reductions in relative risk from childhood
imprinting were stronger for H1N1 (0.34, 95% CI 0.29–0.42) than for H3N2 (0.71, 95% CI
0.62–0.82). In the second-best model, HA subtype-specific imprinting, estimated reductions in
H3N2 risk were particularly weak, and the confidence interval overlapped the null value of 1.
Table 2 shows parameter estimates and 95% profile confidence intervals from all models
fitted.
Effect of evolutionary rate
To test for effects of evolutionary rate on epidemic age distribution, we searched for
decreases in the proportion of cases among children in seasons associated with antigenic
novelty, when highly drifted strains might be more able to infect immunologically experi-
enced adults. We defined children as ages 0–10, and verified internally that our analysis of
evolutionary rate was insensitive to our exact choice of age range for children. Consistent
with this expectation, the data showed a slight negative but not significant association
between annual antigenic advance and the fraction of H3N2 cases observed in children (Fig
4A). However, note that no clear relationship emerged between antigenic novelty and the
fraction of cases observed in older children (>10) and adults (Fig 4A). These are the cohorts
in which epidemiological data show the clearest differences between H1N1 and H3N2’s
age-specific impacts (Fig 2); if rate of antigenic evolution is a dominant driver of age-spe-
cific differences in incidence, we would have expected to see clearer evidence of evolution-
ary rate effects among adults cohorts, not just between adults and the youngest children.
The data contained too few influenza seasons with sufficient numbers of confirmed H1N1
cases to support meaningful Spearman correlation coefficients for either pre-2009 or post-
2009 seasonal H1N1 lineages.
Furthermore, if evolutionary rate is the dominant driver of subtype-specific differences in
epidemic age distribution, then when subtypes H1N1 and H3N2 show similar degrees of
annual antigenic advance, their age distributions of cases should appear more similar. How-
ever, the data showed that differences in H1N1 and H3N2’s age-specific impacts did not con-
verge when lineages showed similar annual advance. When comparing the fraction of cases
observed in specific age classes, H1N1 data consistently clustered separately from H3N2, with
H1N1 consistently causing fewer cases at the extremes of age (children 0–10 and elderly adults
71–85), but more cases in middle-aged adults, regardless of antigenic novelty (Fig 4A).
Smoothed density plots showed no clear relationship between annual antigenic advance and
age distribution (Fig 4B). Overall, the data showed a weak, but not significant signal that rela-
tively severe, clinically attended cases may be more restricted to young children when anti-
genic novelty is low, but the data did not show strong evidence that the magnitude of annual
antigenic drift is a systematic driver of epidemic age distribution across the entire population.
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Discussion
We analyzed a large epidemiological surveillance dataset and found that seasonal influenza
subtypes H1N1 and H3N2 cause different age distributions of relatively severe, clinically
attended cases, confirming previously reported patterns [12–14]. We analyzed several possible
drivers of these differences systematically, and found the greatest support for imprinting pro-
tection against seasonal influenza viruses of the same NA or HA subtype as the first influenza
strain encountered in childhood [12,13]. The data did not support strong effects from broader
HA group-level imprinting, as recently detected for novel zoonotic or pandemic viruses [9,11],
or from differences in rates of antigenic evolution [32]. Our results suggest individuals retain a
lifelong bias in immune memory, and that this imprint is not erased even after decades of
exposure to or vaccination against dissimilar influenza subtypes.
External evidence corroborates the idea that birth year, rather than age, drives subtype-spe-
cific differences in seasonal influenza risk. When H3N2 first emerged in 1968, it caused little
or no excess mortality in the elderly, who had putatively been exposed, as children or young
Fig 4. Effect of antigenic advance on age distribution. (A) Relationship between annual antigenic advance and the fraction of cases observed in
children (0–10), or in adult age groups. Each data point represents a single influenza season in which at least 100 confirmed cases of a given
subtype were observed. Blue label shows Spearman correlation between the fraction of H3N2 cases observed in each age group and annual
antigenic advance. Blue dashes show linear trend fitted using lm() in R. (B) Season-specific age distributions of cases, colored by antigenic
advance since the previous season.
https://doi.org/10.1371/journal.ppat.1008109.g004
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adults, to an H3 virus that had circulated in the late 1800s [7,9]. Meanwhile, H1N1-imprinted
cohorts (those ~10–50 years old at the time) experienced considerable excess mortality in the
1968 pandemic [7]. Now, fifty years later, the same H1N1-imprinted cohorts continue to expe-
rience excess H3N2 morbidity and mortality as older adults [12–14,31] (Fig 2).
In model comparison, the data supported childhood imprinting to NA at the subtype level.
Although NA is not as intensively studied as HA, these results emphasize the increasingly rec-
ognized importance of both antigens as drivers of protection against seasonal influenza [18–
20]. Realistically, some combination of effects from both HA and NA subtype-level imprinting
probably shapes seasonal influenza risk; both models of imprinting produced similar fits to
data, and far outperformed other models in terms of AIC (Fig 3). Unfortunately, due to the
limited diversity of seasonal influenza subtypes that have circulated in humans over the past
century, collinearities between even the relatively simple models tested here prevented us from
testing more complicated models of combined effects from imprinting to multiple antigens.
Deeper insights into the respective roles of HA and NA will most likely need to come from
focused immunological cohort studies, in which individual histories of influenza infection are
recorded and can be studied alongside changes in serology, PBMCs, and/or the B cell reper-
toire [35]. Alternatively, the development of immunological biomarkers for diagnosis of
imprinting status in individual patients could substantially increase the power of epidemiologi-
cal inference.
We did not detect a clear relationship between annual antigenic advance and epidemic age
distribution, although small sample sizes may have limited our statistical power. We did detect
a weak trend, consistent with the idea that influenza cases are more restricted to immunologi-
cally inexperienced children in seasons of low antigenic advance, as previously proposed [32].
But the data did not reveal a clear relationship between antigenic advance and the fraction of
cases occurring in adult age groups, where epidemiological data reveal distinct subtype-specific
differences in impact. Perhaps antigenic advance shapes how cases are distributed between
children and adults, but has small or inconsistent impacts within the adult population. We
speculate that clearer relationships between antigenic advance and epidemic age distribution
might emerge if methods to estimate antigenic distance were able to incorporate effects such
as immune history [42], glycosylation [42,43], and immunity to antigens other than HA
[19,20,44].
The exact immunological drivers of imprinting protection against seasonal influenza
remain unclear, but our results provide some new clues. Traditionally, within-subtype cross-
protection is thought to decay quickly with antigenic drift. Strains that circulated more than 14
years apart rarely show measurable cross-protective titers by the hemagglutination inhibition
(HI) assay [40]. The short timescale of immune memory to variable HA head epitopes stands
in contrast to patterns observed in our study and others [12–14], where within-subtype
immune memory imprinted in childhood appears to persist for an entire human lifetime,
remaining evident even in the oldest cohorts. We speculate that within-subtype imprinting
protection may involve epitopes that are more conserved, and stable over time, than those typi-
cally measured in HI assays. These inform most existing estimates of antigenic distance, but
disproportionately measure antibodies to variable, immunodominant epitopes on the HA
head [15,24]. Across a lifetime of exposures to diverse H1N1 and H3N2 variants, repeated
back-boosting of antibodies to intermediately conserved sites on HA or NA (i.e. sites con-
served within but not across HA and NA subtypes), could explain the longevity of subtype-
level imprinting protection. This is consistent with recent evidence that the immune repertoire
shifts to focus on more conserved influenza epitopes as we age [27,28].
Another possibility is that memory B cell clones developed during the first childhood influ-
enza infection may later adapt via somatic hypermutation to follow antigenic targets as they
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drift over time. However, this would be inconsistent with new evidence suggesting memory B
cells are relatively fixed in phenotype, and have little potential for ongoing affinity maturation
[45,46], or that somatic hypermutation decreases with age [27]. Finally, the role of CD4+ T
cells in imprinting is unclear, but T cell memory and T cell help to B cells within germinal cen-
ters both play at least some role in the development of the immune repertoire [47].
Signals of imprinting protection are anomalously strong in the current cohort of elderly
adults, as reflected by higher estimates of imprinting protection to H1N1 than H3N2. The old-
est subjects in our data, born slightly after 1918, and would not have encountered an influenza
virus of any subtype other than H1N1 until roughly age 30. Repeated early-life exposures to
diverse H1N1 variants may have reinforced and expanded the breadth of H1N1-specific
immune memory [5,48]. But this strong H1N1 protection seems to come at a cost; even after
decades of seasonal H3N2 exposure, and vaccination, older cohorts have evidently failed to
develop equally strong protection against H3N2. HA group 1 antigens (e.g. H1) appear to
induce narrower immune responses, and less cross-group protection than structurally distinct
HA group 2 antigens (e.g. H3) [25]. Perhaps elderly cohorts imprinted to group 1 antigens
have been trapped in narrower responses that offer exceptional protection against strains simi-
lar to that of first exposure but relatively poor adaptability to other subtypes.
We speculate that imprinting protection, which currently limits the number of severe, clini-
cally-attended H1N1 cases in the elderly, also limits the mortality impact of H1N1 viruses.
Although pre- and post- 2009 H1N1 lineages have caused slightly different profiles of age-spe-
cific mortality [13], neither H1N1 lineage causes nearly as many deaths as H3N2 in high-risk
elderly cohorts [13,31,49]. On the one hand, if strong subtype-specific biases from imprinting
remain in future cohorts of elderly adults, our results would corroborate the idea that mortality
from H1N1 may increase as protection in the elderly shifts from H1N1 toward other subtypes
[9,13]. On the other hand, given that cohorts born after 1968 have had much more varied early
life exposures to both H1N1 and H3N2, these cohorts may show a greater ability to act as
immunological generalists as they become elderly, capable of effective defense against multiple
subtypes.
Our study has several limitations. Relatively severe, clinically attended cases are much more
likely to be detected, confirmed to subtype, and included in our data than mild cases. Thus,
while our results show a clear relationship between subtype-level imprinting and risk of rela-
tively severe, clinically attended influenza, the relationship between imprinting and mild or
asymptomatic cases could not be determined from available data.
Given the limited number of variables recorded in the data, we could not model explicitly
the impact of individual risk factors such as the presence of comorbidities, patient sex, or vac-
cination status. All these factors are known to shape immunity and influenza risk [50], and all
may cause individual imprinting outcomes to vary from the average, population trends mea-
sured by our study. Understanding how these patient-level covariates modulate imprinting
and other aspects of immunity is the next frontier in this line of research. For now, working
within the constraints of the available data, we designed the age-specific risk component of the
model to capture empirically the combined effects of several risk factors that could not be
modeled individually. Additionally, we analyzed the relative count of H1N1 to H3N2 cases
within each single year of birth, not absolute incidence, to control for minor age-specific biases
in sampling, which are almost inevitably present in any large surveillance data set.
Another limitation was the low number of confirmed cases available in the pre-2009 era.
Large, detailed data sets collected continuously over decades provide the greatest power to sep-
arate the effects of age from birth year. We emphatically echo earlier calls [51] for more sys-
tematic sharing of single year-of-age influenza surveillance data, standardization of sampling
effort, and reporting of age-specific denominators, which could substantially boost the
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scientific community’s ability to link influenza’s genetic and antigenic properties with epide-
miological outcomes. Additionally, collection and reporting of covariates such as sex, vaccina-
tion status and the presence of comorbidities in surveillance data would help us understand
how patient-level variables modulate imprinting, and immunity in general [52,53].
Altogether, this analysis confirms that the epidemiological burden of H1N1 and H3N2 is
shaped by cohort-specific differences in childhood imprinting [9,12,13,16,54], and that this
imprinting acts at the HA or NA subtype level against seasonal influenza [16,17]. The lack of
support for broader, HA group-level imprinting effects emphasizes the consequences of
immunodominance of influenza’s most variable epitopes, and the difficulty of deploying
broadly protective memory B cell responses against familiar, seasonal strains. Overall, these
findings advance our understanding of how antigenic seniority shapes cohort-specific risk
during epidemics. The fact that elderly cohorts show relatively weak immune protection
against H3N2, even after living through decades of seasonal exposure to or vaccination against
H3N2, suggests that antibody responses acquired in adulthood do not provide the same
strength or durability of immune protection as responses primed in childhood. Immunological
experiments that consider multiple viral exposures, and cohort studies in which individual his-
tories of influenza infection are tracked from birth, promise to illuminate how B cell and T cell
memory develop across a series of early life exposures. In particular, these studies may provide
clearer insights than epidemiological data into which influenza antigens, epitopes and immune
effectors play the greatest role in immune imprinting, and how quickly subtype-specific biases
become entrenched across the first or the first few exposures.
Materials and methods
Ethics statement
This study analyzed only existing epidemiological data, which was completely anonymized.
Estimation of age from birth year in ADHS data
The data contained three variables, influenza season, birth year and confirmed subtype. For
most cases, birth year was extracted directly from the reported date of birth in patient medical
records, but age was not known. We estimated patient age at the time case observation using
the formula [year of observation]-[birth year]. To ensure that the minimum estimated age was
0, the second year in the influenza season of case observation was considered the calendar year
of observation (e.g. 2013 for the 2012–2013 season).
Splines
In Fig 2, smoothing splines were fit to aid visual interpretation of noisy data. We fit splines
using the command smooth.spline(x = AGE, y = FRACTIONS, spar = 0.8) in R version 3.5.0.
Variables AGE and FRACTIONS were vectors whose entries represented single years of age,
and the fraction of cases observed in the corresponding age group. The smoothing parameter
0.8 was chosen to provide a visually smooth fit. Alternative smoothing parameter choices (0.6
& 1.0) are shown in S1 and S2 Figs. Although the choice of smoothing parameter changed the
shape of each fitted spline, qualitative differences between splines fitted to H1N1 or H3N2
were insensitive.
Model formulation
For each unique season in which cases were observed, define p as a vector whose entries repre-
sent the expected probability that a randomly drawn H1N1 or a randomly drawn H3N2 case
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was observed in an individual born in year b. Each model defined p as a linear combination of
age-specific risk, birth year-specific risk (i.e. imprinting effects) and demographic age distribu-
tion. All tested models were nested within the equation:
p ¼ DA � 1H1N1ðIH1N1Þ � 1H3N2ðIH3N2Þ 1
To include risk factors that only modulated risk from one subtype, we included indicator
functions 1H1N1 and 1H3N2, which took value 1 if p described the expected age distribution of
H1N1 or H3N2 cases, respectively, and 0 otherwise.
Demographic age distribution (D). The population of Arizona aged slightly across the
study period, so we controlled for shifting demography in all tested models. Demographic age
distribution was obtained from intercensal estimates of total population (both sexes) for the
state of Arizona, based on the 2000 and 2010 census [55]. The US Census Bureau reports popu-
lation estimates for ages 0–84, but only provides an aggregate estimate for ages 85+. We
impute the number of individuals in each single year of age over 85 using a linear model fit to
data on age 75–84, with a minimum threshold of 1000 individuals per single year of age. State-
specific population estimates were not available prior to the 2000 census, so we substituted
estimates from the year 2000 for cases observed in the 1993–94, and the 1994–95 seasons. Vec-
tor D represented the fraction of the total population at the time of case observation that fell in
a given birth year.
Age-specific risk (A). Age-specific risk was defined as a step function, in which relative
risk was fixed to value 1 in an arbitrarily chosen age bin, and then z-1 free parameters, denoted
r2 to rz, were fit to describe relative risk in all other age bins. Below, 1i are indicator functions
specifying whether each vector entry is a member of age bin i.
A ¼ 11 þ 12r2 þ � � �1zrz 2
To obtain the predicted fraction of cases observed in each single year of birth, we normal-
ized so that the product of vectors representing demographic age distribution, and age-specific
risk, (DA in Eq 1) summed to 1. Thus, vector DA can be interpreted as the expected distribu-
tion of cases of any influenza case (either subtype), in the absence of birth year-specific biases
from imprinting.
Imprinting (I). An indicator function defined whether a given prediction vector
described risk of confirmed H1N1 or H3N2. Let fIHxNy be vectors describing the fraction of
cases of each birth year that were protected against strain HxNy by their childhood imprinting.
We defined rIHxNy as free parameters describing the risk of confirmed HxNy, given imprinting
protection. Finally, the factor describing the effect of imprinting (I) was defined as:
IHxNy ¼ 1HxNy � ½fIHxNyrIHxNy þ ð1   fIHxNyÞ� 3
Likelihood
We used Eqs 1–3 to generate predicted case age distributions (p) for each influenza season (s)
in which cases were observed in the data. Then, the likelihood was obtained as a product of
multinomial densities across all seasons. If ns represents the total number of cases observed in
a given season, x0cs,. . .xmcs each represent the number of cases observed in each single year of
birth, and if p0cs. . .pmcs each represent entries in the model’s predicted birth year-distribution
of cases, then the likelihood is given by:
L ¼
Q
s
ns!
x0s! . . . xms!
px0s0s . . . pxmsms 4
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Model fitting and model comparison
We fit models containing all possible combinations of the above factors to the surveillance
data. We simultaneously estimated all free parameter values using the optim() function in R,
with method L-BFGS-B. Imprinting parameters could take values in [0,1], representing the
possibility of a reduction in risk. Age-specific risk parameters could take any value greater
than 0. We calculated likelihood profiles and 95% profile confidence intervals for each free
parameter. Confidence intervals were defined using the method of likelihood ratios [36].
Antigenic advance
We obtained antigenic distance estimates from Nextstrain (nextstrain.org) [38,56], and from
source data from Fig 3 in Bedford et al. [40]. Nextstrain calculates antigenic distance using
genetic data from GISAID [57], and using methods described by Neher et al. [39]. We ana-
lyzed “CTiter” estimates from Nextstrain, which correspond to Neher et al.’s tree model
method, and are most directly comparable to pre-2009 H1N1 estimates from [40]. We
repeated analyses using estimates from Neher et al.’s substitution model method and verified
that our choice of antigenic distance metric did not meaningfully impact our results. The nega-
tive Spearman correlation between antigenic advance and proportion of cases in children was
lower, but still not statistically significant when using the substitution model (p = 0.06); all
other differences were unremarkable. Datasets from Nextstrain and Bedford et al. both con-
tained redundant antigenic distance estimates for the H3N2 subtype, but for subtype H1N1,
only Bedford et al. analyzed the pre-2009 lineage, and only Nextstrain data analyzed the post-
2009 lineage. The antigenic distance estimates reported by Bedford et al. were roughly propor-
tional to those reported on Nextstrain, but greater in absolute magnitude [39]. To enable visu-
alization of all lineages of H1N1 and H3N2 on the same plot axes, we rescaled pre-2009 H1N1
estimates from Bedford et al. using the formula dNextstrain = 0.47dBedford. The scaling factor was
chosen so that directly-comparable H3N2 distance estimates obtained using each method
spanned the same range (S3 Fig). The Nextstrain data files used in this analysis are archived
within our analysis code.
Supporting information
S1 Fig. ADHS age distributions, all seasons. Supplement to Fig 2 showing observed age dis-
tributions from all influenza seasons. Observed case fractions (points) were only plotted if 10
or more cases of a given subtype were confirmed, to avoid extreme stretching of the y axis.
Smoothing splines were only plotted if 50 or more cases of a given subtype were observed, as
fits to fewer data points would not have been meaningful.
(TIFF)
S2 Fig. Alternate smoothing parameters, AZDHS data. Supplement to Fig 2, with smooth-
ing parameters chosen to fit splines that are less (A-F), or more (G-L) smooth than the splines
shown in the main text. Differences between H1N1 and H3N2’s age-specific impacts remain
evident, especially in the oldest cohorts, regardless of smoothness.
(PDF)
S3 Fig. Comparison of rescaled antigenic distance estimates from the Bedford et al., and
Nextstrain datasets. Points represent average antigenic position of all isolates from a given
calendar year.
(TIFF)
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S1 Data. PCR-confirmed cases from ADHS surveillance, and state-level census data.
(ZIP)
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